VS

Vikram Singh Kang

Director Director DIN 07562870
DIN 07562870 First appointment Apr 2017 Primary industry General Business
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 0 active board seats
Past companies 1 historical roles
Total affiliations 1 Since Apr 2017
Shareholding value Locked Premium profile

About Vikram Singh Kang

Data last updated:

Vikram Singh Kang has 9 years in corporate governance. Formerly with 1 company, such as Euro India Biotech Limited. Engaged in Technology. Contributes to corporate operations.

DIN 07562870
Primary Designation Director
First Appointment 03 Apr 2017
Oldest Company Age Not Provided

Current companies

No current companies available.

Previous companies

CompanyDesignationAppointmentFoundedStatus
Euro India Biotech Limited U29211CH1992PLC012332
Director03 Apr 20171992Active

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Euro India Biotech Limited
Premium access

Shareholding and investment profile for Vikram Singh Kang

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Vikram Singh Kang

Vikram Singh Kang has 9 years in corporate governance. Formerly with 1 company, such as Euro India Biotech Limited. Engaged in Technology. Contributes to corporate operations.

Vikram Singh Kang is associated with 0 companies as a director.

Vikram Singh Kang has expertise in Technology.

Vikram Singh Kang has 9 years in corporate governance.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available